Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biomarker testing in MCI patients-deciding who to test.
van Maurik IS, Rhodius-Meester HFM, Teunissen CE, Scheltens P, Barkhof F, Palmqvist S, Hansson O, van der Flier WM, Berkhof J. van Maurik IS, et al. Among authors: van der flier wm. Alzheimers Res Ther. 2021 Jan 7;13(1):14. doi: 10.1186/s13195-020-00763-7. Alzheimers Res Ther. 2021. PMID: 33413634 Free PMC article.
Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design.
de Wilde A, van Maurik IS, Kunneman M, Bouwman F, Zwan M, Willemse EA, Biessels GJ, Minkman M, Pel R, Schoonenboom NS, Smets EM, Wattjes MP, Barkhof F, Stephens A, van Lier EJ, Batrla-Utermann R, Scheltens P, Teunissen CE, van Berckel BN, van der Flier WM. de Wilde A, et al. Among authors: van lier ej, van berckel bn, van der flier wm, van maurik is. Alzheimers Dement (Amst). 2017 Jan 23;6:143-151. doi: 10.1016/j.dadm.2017.01.003. eCollection 2017. Alzheimers Dement (Amst). 2017. PMID: 28239639 Free PMC article.
Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project.
van Maurik IS, Zwan MD, Tijms BM, Bouwman FH, Teunissen CE, Scheltens P, Wattjes MP, Barkhof F, Berkhof J, van der Flier WM; Alzheimer’s Disease Neuroimaging Initiative. van Maurik IS, et al. Among authors: van der flier wm. JAMA Neurol. 2017 Dec 1;74(12):1481-1491. doi: 10.1001/jamaneurol.2017.2712. JAMA Neurol. 2017. PMID: 29049480 Free PMC article.
Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two-dimensional phase-contrast magnetic resonance imaging.
Leijenaar JF, van Maurik IS, Kuijer JPA, van der Flier WM, Scheltens P, Barkhof F, Prins ND. Leijenaar JF, et al. Among authors: van der flier wm, van maurik is. Alzheimers Dement (Amst). 2017 Nov 2;9:76-83. doi: 10.1016/j.dadm.2017.10.001. eCollection 2017. Alzheimers Dement (Amst). 2017. PMID: 29234724 Free PMC article.
Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer's disease biomarkers in a nonacademic, multicenter memory clinic cohort: The ABIDE project.
Willemse EAJ, van Maurik IS, Tijms BM, Bouwman FH, Franke A, Hubeek I, Boelaarts L, Claus JJ, Korf ESC, van Marum RJ, Roks G, Schoonenboom N, Verwey N, Zwan MD, Wahl S, van der Flier WM, Teunissen CE. Willemse EAJ, et al. Among authors: van marum rj, van der flier wm, van maurik is. Alzheimers Dement (Amst). 2018 Sep 12;10:563-572. doi: 10.1016/j.dadm.2018.08.006. eCollection 2018. Alzheimers Dement (Amst). 2018. PMID: 30406175 Free PMC article.
Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project.
van Maurik IS, Slot RER, Verfaillie SCJ, Zwan MD, Bouwman FH, Prins ND, Teunissen CE, Scheltens P, Barkhof F, Wattjes MP, Molinuevo JL, Rami L, Wolfsgruber S, Peters O, Jessen F, Berkhof J, van der Flier WM; Alzheimer’s Disease Neuroimaging Initiative. van Maurik IS, et al. Among authors: van der flier wm. Alzheimers Res Ther. 2019 Apr 16;11(1):33. doi: 10.1186/s13195-019-0487-y. Alzheimers Res Ther. 2019. PMID: 30987684 Free PMC article.
Development and Usability of ADappt: Web-Based Tool to Support Clinicians, Patients, and Caregivers in the Diagnosis of Mild Cognitive Impairment and Alzheimer Disease.
van Maurik IS, Visser LN, Pel-Littel RE, van Buchem MM, Zwan MD, Kunneman M, Pelkmans W, Bouwman FH, Minkman M, Schoonenboom N, Scheltens P, Smets EM, van der Flier WM. van Maurik IS, et al. Among authors: van der flier wm, van buchem mm. JMIR Form Res. 2019 Jul 8;3(3):e13417. doi: 10.2196/13417. JMIR Form Res. 2019. PMID: 31287061 Free PMC article.
Cognitive and functional progression of dementia in two longitudinal studies.
Wang Y, Haaksma ML, Ramakers IHGB, Verhey FRJ, van de Flier WM, Scheltens P, van Maurik I, Olde Rikkert MGM, Leoutsakos JS, Melis RJF. Wang Y, et al. Int J Geriatr Psychiatry. 2019 Nov;34(11):1623-1632. doi: 10.1002/gps.5175. Epub 2019 Jul 26. Int J Geriatr Psychiatry. 2019. PMID: 31318090 Free PMC article.
Clinician-patient communication during the diagnostic workup: The ABIDE project.
Visser LNC, Kunneman M, Murugesu L, van Maurik I, Zwan M, Bouwman FH, Schuur J, Wind HA, Blaauw MSJ, Kragt JJ, Roks G, Boelaarts L, Schipper AC, Schooneboom N, Scheltens P, van der Flier WM, Smets EMA. Visser LNC, et al. Alzheimers Dement (Amst). 2019 Jul 29;11:520-528. doi: 10.1016/j.dadm.2019.06.001. eCollection 2019 Dec. Alzheimers Dement (Amst). 2019. PMID: 31388556 Free PMC article.
Added value of amyloid PET in individualized risk predictions for MCI patients.
van Maurik IS, van der Kall LM, de Wilde A, Bouwman FH, Scheltens P, van Berckel BNM, Berkhof J, van der Flier WM. van Maurik IS, et al. Among authors: van berckel bnm, van der flier wm, van der kall lm. Alzheimers Dement (Amst). 2019 Jul 29;11:529-537. doi: 10.1016/j.dadm.2019.04.011. eCollection 2019 Dec. Alzheimers Dement (Amst). 2019. PMID: 31388557 Free PMC article.
37 results